Violeta Sánchez

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer”.

NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0519

N/A

0.631DataRank · unranked

66 citations

Xiaopeng Sun, Paula I. González-Ericsson, Violeta Sánchez, Melinda E. Sanders, Elizabeth C. Wescott +15 more

Changes in Peripheral and Local Tumor Immunity after Neoadjuvant Chemotherapy Reshape Clinical Outcomes in Patients with Breast Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3685

N/A

0.617DataRank · unranked

60 citations

Mellissa J. Nixon, Paula I. González-Ericsson, Riley E. Bergman, Mark A. Pilkinton, Wyatt J. McDonnell +21 more

Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2023-007736

N/A

0.510DataRank · unranked

29 citations

Brandie C. Taylor, Margaret L. Axelrod, Xiaopeng Sun, Lindsey N. Guerin, Paula I. González-Ericsson +9 more

Tissue-specific expression of p73 and p63 isoforms in human tissues

Cell Death and Disease(2021)10.1038/s41419-021-04017-8

N/A

0.505DataRank · unranked

28 citations

J. Scott Beeler, Brian D. Lehmann, Paula I. González-Ericsson, Violeta Sánchez, Melinda E. Sanders +3 more

Obesity and metabolic syndrome are associated with short-term endocrine therapy resistance in early ER + breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06794-y

N/A

0.360DataRank · unranked

10 citations

Yvonne A. Berko, Violeta Sánchez, Melinda E. Sanders, Paula I. González-Ericsson, Carlos L. Arteaga +2 more

Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer

Breast Cancer Research(2022)10.1186/s13058-022-01542-y

N/A

0.360DataRank · unranked

10 citations

Mellissa J. Nixon, Mónica V. Estrada, Violeta Sánchez, Quanhu Sheng, Susan R. Opalenik +9 more

Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific Manner

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-2009

N/A

0.208DataRank · unranked

3 citations

Chad R. Potts, Leo Y. Luo, Brad A. Davidson, Riley E. Bergman, J. Kemp +14 more

Data from Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells

(2023)10.1158/1078-0432.c.6517720.v1

N/A

0DataRank · unranked

0 citations

James T. Forbes, Chirayu Shah, Shelby K. Wyatt, H. Charles Manning, Maria G. Olivares +9 more

Structural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy

Nature Communications(2024)10.1038/s41467-024-45609-0

N/A

0DataRank · unranked

46 citations

Shrusti S. Patel, Justin H. Lo, Ashley Cavnar, Lauren M. Babb, Nora Francini +17 more

Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancer

JCI Insight(2025)10.1172/jci.insight.187151

N/A

0DataRank · unranked

2 citations

Hong Yuen Wong, Jorgen Jackson, Monika Antunovic, Brenda Rios, Evan Watkins +17 more

Monitoring systemic immune responses to checkpoint inhibition in breast cancer reveals host responses and mechanisms of resistance

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-012606

N/A

0DataRank · unranked

2 citations

Xiaopeng Sun, Quanhu Sheng, Paula I. González-Ericsson, Elizabeth C. Wescott, Brandie C. Taylor +8 more

TREM2 expressing macrophages are not associated with prognostic markers or metabolic syndrome in early stage ER positive breast cancer

Scientific Reports(2025)10.1038/s41598-025-22614-x

N/A

0DataRank · unranked

0 citations

Guadalupe Garcia, Violeta Sánchez, Paula I. González-Ericsson, Barbara Fingleton, Alyssa H. Hasty +2 more

MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBC

JCI Insight(2020)10.1172/jci.insight.134290

N/A

0DataRank · unranked

49 citations

Joe T. Sharick, Paula I. González-Ericsson, Violeta Sánchez, Phillip T. Dean, Susan R. Opalenik +14 more

Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti–PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0607

N/A

0DataRank · unranked

91 citations

Julia D. Wulfkhule, Rosa I. Gallagher, Xiaopeng Sun, Margaret L. Axelrod, Quanhu Sheng +10 more

Hierarchical tumor heterogeneity mediated by cell contact between distinct genetic subclones

Journal of Clinical Investigation(2021)10.1172/jci143557

N/A

0DataRank · unranked

17 citations

Ian Waters, Lauren Dennison, David Chu, Joshua Donaldson, Dong Ho Shin +17 more

Structural Optimization of siRNA Conjugates for Albumin Binding Achieves Effective MCL1-Targeted Cancer Therapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.14.528574

N/A

0DataRank · unranked

2 citations

Shrusti S. Patel, Ashley Cavnar, Justin H. Lo, Lauren M. Babb, Nora Francini +16 more

Data from A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer

(2023)10.1158/0008-5472.c.6503028.v1

N/A

0DataRank · unranked

0 citations

Todd W. Miller, Justin M. Balko, María G. Kuba, Violeta Sánchez, R. Adam Smith +9 more

Data from Inhibition of Mammalian Target of Rapamycin Is Required for Optimal Antitumor Effect of HER2 Inhibitors against HER2-Overexpressing Cancer Cells

(2023)10.1158/1078-0432.c.6517720

N/A

0DataRank · unranked

0 citations

James T. Forbes, Chirayu Shah, Shelby K. Wyatt, H. Charles Manning, Maria G. Olivares +9 more